Mumbai-headquartered drugmaker Cipla Ltd is bolstering its focus on a pipeline of drugs to fight infections caused by ...

As antibiotic-resistant "superbugs" make infections trickier to treat, some in the medical community are turning to ...

Wockhardt is advancing Zaynich, a novel antibiotic combination, targeting drug-resistant infections, with plans for regulatory submissions in the US and India. The company is exploring out-licensing ...

Microplastics aren’t just everywhere — they might be turning your dinner into a breeding ground for supercharged pathogens.

Because COVID-19 is caused by a virus, antibiotics cannot be used to treat it. However, Pulia says physicians may feel they ...

Now, though, antibiotic resistance in bacteria is a growing problem. The issue has been well-reported in humans; infections such as MRSA (Methicillin-resistant Staphylococcus aureus) are often called ...

Bacteria are ubiquitous microscopic organisms capable of rapid growth. While beneficial strains like lactic acid bacteria (LAB) promote gut health and ...

Antibiotics are one of the greatest triumphs in the history of medical science—but these lifesaving tools have a dark side.

Over 660 million pilgrims gathered at the Maha Kumbh Mela in Prayagraj, India, this past February, and I'm now seeing the ...

Basel-based BioVersys stands to receive CHF 5 million upfront under the terms of the deal, which could be worth up to CHF 479 ...

AbbVie has claimed FDA approval for Emblaveo, a new antibiotic product to treat complicated intra-abdominal infections (cIAI), including those caused by Gram-negative bacteria that represent a ...